
Network News

Germany’s most important award for young scientists honors the development of immunotherapies against malignant brain tumors. Using immune cells to fight brain tumors – that is the goal of Lukas Bunse, who is this year’s recipient of the Heinz Maier-Leibnitz Prize from the German Research Foundation (DFG). The physician and scientist is being honored for […]
read more
Batene: Energy boost for batteries
An electric car costs more than a comparable combustion engine because the battery is so expensive. And hardly any model gets as far on one charge as an average car on one tank of gas. Batene GmbH, a spin-off from the Max Planck Institute for Medical Research, wants to change this. The start-up is developing […]
read more
Robot navigates precisely to changes in the lungs
One of the most modern methods for diagnosing lung cancer is now available in the Thorax Clinic at Heidelberg University Hospital – robot-assisted bronchoscopy. With the steerable robotic catheter, small and unfavorably located abnormalities in the lung tissue can be reached more easily than before. The clinic is therefore ideally equipped for the start of […]
read more
Otto Warburg Medal 2025 goes to Matthias Hentze
In recognition of his fundamental contributions to the understanding of gene regulation by RNA-binding proteins and the identification of RNA-binding proteins, Prof. Dr. Matthias Hentze is awarded the Otto Warburg Medal 2025 of the Society for Biochemistry and Molecular Biology. More Information in German below. Otto-Warburg-Medaille 2025 geht an Matthias Hentze In Anerkennung seiner fundamentalen […]
read more
Medizin im digitalen Zeitalter: Forum Gesundheitsstandort präsentiert Technologie-Projekte bei der DMEA 2025
(Stuttgart, 26.03.2025) Daten retten Leben. Denn mit neuen Technologien und mit der Unterstützung von Künstlicher Intelligenz lassen sich riesige Mengen medizinischer Daten verlässlicher als je zuvor auswerten. So können Krankheiten frühzeitiger erkannt und behandelt werden. Dazu aber gilt es, die Daten optimal miteinander zu vernetzen, damit Ärztinnen, Ärzte, Kliniken und Pflegende ihre Patientinnen und Patienten bestmöglich […]
read more
Hummingbird Diagnostics Announces Publication Evaluating miR-Blood’s Small RNA Expression Dataset Capabilities in Nature’s Scientific Data
miR-Blood is capable of revealing highly cell-type specific patterns of small RNA expression HEIDELBERG, Germany, March 06, 2024 – Hummingbird Diagnostics GmbH, a leader in using blood-based small RNAs for early disease detection and characterization, today announced a publication in Scientific Data, a peer-reviewed, open-access journal launched by Nature. The study evaluated miR-Blood, Hummingbird Diagnostics’ […]
read more
Research Campus M²OLIE for Improved Cancer Treatment
Third funding phase for collaboration between research and industry – BMBF funds five-year project with ten million euros The goal of the interdisciplinary research campus “Mannheim Molecular Intervention Environment” (M²OLIE) is to provide tailored treatment for cancer patients with oligometastases that is both minimally invasive and efficient. Based at the Mannheim University Hospital, 25 research […]
read more
AGC Biologics Honored for Excellence in Contract Development and Manufacturing
Today, we announced that our company won two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough […]
read more
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.
Basel, Switzerland, 12 March 2025 – Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez™ micro-bioreactor platform into its process development. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by enabling highly efficient, scalable perfusion-based bioprocessing from early-stage development to […]
read more